Wells Fargo’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-50,000
Closed -$28K – 6565
2019
Q4
$28K Buy
+50,000
New +$2.41M ﹤0.01% 5663
2018
Q4
– Sell
-600
Closed -$1K – 6529
2018
Q3
$1K Buy
+600
New +$27.4K ﹤0.01% 6308
2018
Q1
– Sell
-125,100
Closed -$11K – 6488
2017
Q4
$11K Hold
125,100
– – ﹤0.01% 5907
2017
Q3
$54K Sell
125,100
-9,540
-7% -$465K ﹤0.01% 5443
2017
Q2
$111K Sell
134,640
-12,566
-9% -$583K ﹤0.01% 5118
2017
Q1
$263K Buy
147,206
+35,006
+31% +$1.67M ﹤0.01% 4641
2016
Q4
$70K Buy
+112,200
New +$5.15M ﹤0.01% 5288
2015
Q3
– Sell
-5,834
Closed -$6K – 6338
2015
Q2
$6K Buy
+5,834
New +$276K ﹤0.01% 5962
2014
Q2
– Sell
-145,411
Closed -$159K – 6212
2014
Q1
$159K Buy
+145,411
New +$6.68M ﹤0.01% 4444

Other funds holding MET

Wells Fargo's MET Position: Q2 2026 in Review

Wells Fargo reduced its MetLife (MET) stake by 6% in Q2 2026, selling an estimated $7.53M and leaving 1,450,511 shares worth $123M. The position accounts for 0.02% of the portfolio, ranked #584.

Wells Fargo first reported a position in MET in Q2 2013 and has held it in 53 quarters since. The position peaked at $353M in Q2 2017. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Wells Fargo held 1,450,511 shares of MetLife worth $123M as of Q2 2026.
  • Wells Fargo sold 93,333 MetLife shares in Q2 2026, an estimated $7.53M.
  • MetLife made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #584 holding.
  • Wells Fargo first reported a position in MetLife in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's MetLife position peaked at $353M in Q2 2017.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.